Glioblastoma is notorious for its rapid growth, invasive behavior and limited response to current therapies. Surgery, radiation and chemotherapy can reduce the visible tumor burden, but malignant cells often infiltrate surrounding brain tissue, making complete removal difficult. The disease also frequently returns after treatment. Scientists have increasingly focused on tumor-initiating cells, often called glioblastoma stem-like cells, because these cells may possess the ability to self-renew, generate diverse tumor cell populations and survive conditions that eliminate more differentiated cancer cells.

The subventricular zone, or SVZ, is a narrow region lining the lateral ventricles of the brain. It is one of the areas most closely associated with neural stem and progenitor cells, particularly in experimental models and during specific stages of human brain development. These cells can divide, migrate and produce different neural cell types. Because of their long-term self-renewal capacity and proximity to regions connected by brain fluid pathways, researchers have proposed that the SVZ could provide a cellular or environmental context in which malignant transformation occurs.

The new research addresses this possibility by focusing on cells isolated from the SVZ and examining whether they display characteristics associated with glioblastoma origin or tumor-initiating populations. Isolation is a critical step in this type of investigation because brain tissue contains many cell types, including mature neurons, glial cells, vascular cells, immune cells and resident progenitors. Separating a rare population from this complex mixture allows researchers to study its growth behavior, morphology and molecular profile without immediately conflating normal neural stem cells with cancer cells.

Characterization of such cells typically involves several complementary approaches. Researchers may assess whether cells can survive and expand under defined culture conditions, form stem-like clusters, or generate progeny with different cellular features. They may also examine the expression of proteins associated with neural stemness, glial identity, proliferation and malignancy. Molecular comparisons with established glioblastoma cells or tumor specimens can help determine whether the isolated population shares a meaningful biological signature with cancer-associated cells. The value of the study lies in combining these observations rather than relying on a single marker.

The term “origin-like” is especially important. It does not establish that the isolated SVZ cells directly give rise to glioblastoma in patients. Demonstrating a true cell of origin requires evidence that a defined normal cell population undergoes specific genetic or epigenetic changes and initiates tumors in appropriate experimental systems. Similarities in morphology, growth or gene expression can indicate developmental relationships, but they cannot by themselves prove a direct lineage. The authors’ cautious wording reflects the complexity of distinguishing a normal neural precursor from a transformed cell with tumor-forming potential.

The findings are nevertheless significant because glioblastoma biology may depend not only on mutations within tumor cells but also on the tissue in which those cells emerge. The SVZ contains signaling molecules, extracellular structures and neighboring cells that can influence proliferation and differentiation. If a subset of SVZ cells is unusually susceptible to malignant transformation, or if the local environment supports the survival of early tumor cells, that could help explain why glioblastoma sometimes appears near ventricular regions and why infiltrating disease can extend along anatomically connected pathways.

A better understanding of these cells could also influence the search for new treatments. Conventional therapies often target rapidly dividing tumor cells, while stem-like populations may remain relatively resistant because they divide slowly, repair DNA damage efficiently or occupy protective microenvironments. Identifying the signals that maintain SVZ-derived, glioblastoma-like cells could reveal vulnerabilities distinct from those found in the bulk tumor. Future strategies might aim to block self-renewal pathways, disrupt interactions with surrounding brain cells, or force malignant stem-like cells into states that make them more sensitive to treatment.

The study may also provide a useful experimental platform for investigating glioblastoma before a fully developed tumor forms. Patient-derived models often capture advanced disease, but they can make it difficult to reconstruct the earliest steps of transformation. Cells with origin-like properties could allow researchers to compare normal neural progenitors, pre-malignant populations and established tumor cells under controlled conditions. Such comparisons could clarify which molecular changes initiate malignancy, which changes support invasion and which are acquired later as the tumor adapts to therapy.

The researchers emphasize a promising but still incomplete link between the SVZ and glioblastoma biology. Their work does not redefine the disease as originating from one universal cell type, nor does it imply that every SVZ neural stem cell is at risk of becoming cancerous. Instead, it adds evidence that specific cells in this specialized brain region may share properties with glioblastoma-initiating populations. Confirming their role will require lineage-tracing studies, genomic analysis, transplantation experiments and validation in patient samples. For now, the discovery strengthens a growing scientific focus on where glioblastoma begins—and on the rare cells that may allow it to return.

Subject of Research: Putative glioblastoma origin-like cells in the brain’s subventricular zone

Article Title: Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization

Article References: Oh, HC., Choi, R.J., Jo, SY. et al. “Putative glioblastoma origin-like cells in the subventricular zone: isolation and characterization.” Experimental & Molecular Medicine (2026). https://doi.org/10.1038/s12276-026-01801-4

Image Credits: AI Generated

DOI: 10.1038/s12276-026-01801-4

Keywords: glioblastoma, subventricular zone, neural stem cells, tumor-initiating cells, cancer stem cells, brain tumors, glioblastoma origin, neuro-oncology

In glioblastoma, the aberrant behavior of cancer stem cells contributes significantly to tumor initiation, resistance to therapies, and recurrence after treatment. These stem cells possess the unique ability to self-renew and differentiate into various types of brain tumors. Understanding the molecular pathways that regulate their properties is critical for developing effective treatment strategies. The researchers focused their investigation on the NSUN7 enzyme and its association with the modification of circular RNA molecules, particularly circNTRK2.

Circular RNAs have emerged as a new class of regulatory molecules in various biological processes. Unlike linear RNAs, these molecules form a covalently closed continuous loop, which allows them to exhibit distinct properties, such as greater stability and unique interaction capabilities with proteins and other RNAs. The researchers hypothesized that circNTRK2 might be involved in temozolomide resistance, a common treatment for glioblastoma. The NSUN7 enzyme plays a pivotal role in the N^5-methylcytosine (m^5C) modification of RNA, which is known to influence RNA stability and function.

In examining the activities of NSUN7, the research team conducted a series of experiments that demonstrated the correlation between NSUN7 expression levels and the stemness properties of glioblastoma cells. Their findings revealed that enhanced NSUN7 activity led to increased m^5C modification of circNTRK2, which in turn activated the STK31 protein. STK31 is crucial for maintaining the stem-like characteristics of glioblastoma cells, suggesting that the m^5C modification serves as a regulatory switch in this context.

One of the most compelling aspects of this research was the demonstration of the functional implications of NSUN7-induced m^5C modification. The authors conducted in vitro assays that showcased how the introduction of a specific inhibitor targeting the NSUN7 enzyme diminished the stemness features of glioblastoma cells. This was accompanied by reduced cell proliferation, increased apoptosis, and diminished abilities to form spheres, a hallmark of stem cell behavior in vitro.

Furthermore, the in vivo component of the study involved the use of xenograft models to evaluate how NSUN7 modulation influences tumor growth and progression in a living organism. The results were striking: tumors derived from cells with inhibited NSUN7 showed significantly reduced growth rates and alterations in their histological characteristics. These findings not only corroborate the role of the NSUN7-circNTRK2-STK31 pathway but also underline its potential as a therapeutic target.

Given the challenges posed by glioblastoma, particularly its notorious resistance to conventional therapies, this research paves the way for novel treatment approaches. By targeting the m^5C modification pathway intertwined within the glioblastoma stem cell compartment, it may be possible to develop strategies that can sensitize tumors to existing treatments while simultaneously depleting their stem-like populations.

Moreover, the implications of this research extend beyond glioblastoma. The N^5-methylcytosine modification is increasingly recognized as a crucial post-transcriptional modification that could influence various other malignancies and cellular contexts. Thus, further exploration into the dynamics of RNA modifications holds promise for broadening our understanding of cancer biology and therapeutic intervention.

While the research makes significant inroads, there are various avenues for future inquiry. The interplay between different RNA modifications, such as m^5C and N6-methyladenosine, is not well understood and could hold keys to unraveling further complexities of RNA regulation in cancer. Additionally, the exploration of the broader RNA landscape in glioblastoma could reveal more targets for intervention and deeper insights into the behaviors of cancer stem cells.

Furthermore, the precise molecular mechanisms through which NSUN7-modified circNTRK2 influences STK31 activity warrant deeper exploration. Understanding the interactions at the molecular level could pave the way toward developing small molecules or biologics that could specifically target these pathways in glioblastoma.

The community eagerly anticipates follow-up studies as they could enrich the conversation surrounding RNA modifications in cancer research. As our understanding of non-coding RNAs and their modifications deepens, the potential for RNA-based therapeutics could become a tangible reality.

In conclusion, the research conducted by Zhao et al. shines a beacon of hope in the fight against glioblastoma, emphasizing the role of RNA modifications in cancer biology. This study not only elucidates a novel regulatory mechanism governing glioblastoma stemness but also opens new doors for potential therapeutic strategies targeting resistant populations in this devastating disease.

Subject of Research: NSUN7-mediated RNA modifications and their impact on glioblastoma stemness.

Article Title: NSUN7-mediated m⁵C modification of circNTRK2 regulates stemness properties of glioblastoma cells by activating STK31.

Article References:

Zhao, Y., Zhang, M., Ma, J. et al. NSUN7-mediated m⁵C modification of circNTRK2 regulates stemness properties of glioblastoma cells by activating STK31. J Transl Med (2025). https://doi.org/10.1186/s12967-025-07484-1

Image Credits: AI Generated

DOI: 10.1186/s12967-025-07484-1

Keywords: glioblastoma, cancer stem cells, RNA modification, NSUN7, circNTRK2, STK31, N^5-methylcytosine.